Agenus reported $21.38M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US $ 2.98B 99M
Acceleron Pharma XLRN:US $ 45.11M 9.64M
Agenus AGEN:US $ 21.38M 4.73M
Amgen AMGN:US $ 1.31B 79M
AstraZeneca AZN:LN 2.99B 412M
Bristol Myers Squibb BMY:US $ 1.79B 95M
Celldex Therapeutics CLDX:US $ 5.82M 1.52M
Chemocentryx CCXI:US $ 19.6M 100K
CSL CSL:AU $ 1.02B 337.5M
Dicerna Pharmaceuticals DRNA:US $ 21.99M 3.47M
Dynavax Technologies DVAX:US $ 26.93M 5.85M
Eli Lilly And LLY:US $ 1.58B 107.8M
Flexion Therapeutics FLXN:US $ 26.99M 423K
Genocea Biosciences GNCA:US $ 3.88M 149K
Gilead Sciences GILD:US $ 1.18B 173M
Glaxosmithkline GSK:US 2.5B 6M
GlaxoSmithKline GSK:LN 2.5B 6M
Immunogen IMGN:US $ 10.3M 569K
Intrexon XON:US $ 18.66M 1.34M
Jiangsu Hengrui Me. 600276:CH 2.7B 181.85M
Johnson & Johnson JNJ:US $ 6B 73M
Karyopharm Therapeutics KPTI:US $ 35.1M 1.43M
Macrogenics MGNX:US $ 17.16M 1.93M
Merck MRK:GR 1.38B 34M
Merk MRK:US $ 2.27B 9M
Northwest Biotherapeutics NWBO:US 6.65M 721K
Novartis NOVN:VX 3.6B 109M
Novavax NVAX:US $ 77.79M 4.63M
Pfizer PFE:US $ 2.73B 61M
Regeneron Pharmaceuticals REGN:US $ 445M 30.3M
Rigel Pharmaceuticals RIGL:US $ 22.88M 499K
Sangamo Biosciences SGMO:US $ 14.5M 1.98M
Veracyte VCYT:US $ 59.54M 39.63M
YTE INCY:US $ 190.7M 21.84M